Transparency Market Research

Meningitis Diagnostic Testing Market 2019; Key Product Segments and Their Future

Transparency Market Research Report Added "Meningitis Diagnostic Testing Market" to its database.


Albany, NY -- (SBWIRE) -- 02/20/2017 -- Meningitis diagnostic testing includes the laboratory tests and imaging studies used to detect the presence of meningitis. Meningitis is a medical condition involving inflammation of the meninges which may be caused by several factors such as bacterial or viral infection.In rare cases, it may be caused due tothe use of certain drugs such as amoxicillin, azathioprine and methotrexate. The market for meningitis diagnostics testing is growing day by day owing to increased chances of infection due to increase in the life expectancy of people across the globe.

Read Full Report:

The global meningitis diagnostic testing market can be segmented on the basis of the source of infection and the tests used for the diagnosis. According to the etiology of meningitis, the meningitis diagnostic tests are categorized as bacterial meningitis test, viral meningitis test and fungal meningitis test. The types of meningitis diagnostic tests include blood tests, culture tests, lumbar puncture (spinal tap) test, computed tomography and Magnetic Resonance Imaging test. Some of the other novel test typesinclude molecular diagnostics, monoclonal antibodies and immunoassays.

Geographically, the global meningitis diagnostic testing market is segmented into four major regions, North America, Europe, Asia-Pacific and Rest of the World. In emerging economies of the world, which includes countries in Asia and Africa, meningitis diagnostic tests such as culture test, CT and MRI forms the major share .Thesediagnostic tests requires longer waiting time for the results. Therefore, development and distribution of innovative and novel tests such as molecular diagnostics and immunoassay is expected to drive the market for meningitis diagnostic tests in the near future. The market for meningitis diagnostic testing is very much established in the developed parts of the world such as the U.S.A., Europe, Japan and Australia and therefore, the demand for advanced, rapid and novel meningitis diagnostic testing is more in this region.

Download exclusive Sample of this report:

Some of the key players in this market are Abbott Laboratories, Inc., Affymetrix, Inc., Beckman Coulter, Inc., BD Company (Becton, Dickinson and Company), Bio-Rad Laboratories, Inc., Diamedix Corporation (subsidiary of IVAX Diagnostics, Inc.), DiaSorinS.p.A., FujirebioDiagnostics, Inc., Gen-Probe, Inc., Hologic, Inc.,Novartis Diagnostics and Ortho-Clinical Diagnostics, Inc.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453